LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 20 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,033 | -55.6% | 3,603 | -41.4% | 0.00% | – |
| Q2 2023 | $45,119 | +11867.9% | 6,147 | +6439.4% | 0.00% | – |
| Q1 2023 | $377 | +99.5% | 94 | +62.1% | 0.00% | – |
| Q4 2022 | $189 | – | 58 | +1.8% | 0.00% | – |
| Q3 2022 | $0 | – | 57 | +62.9% | 0.00% | – |
| Q2 2022 | $0 | – | 35 | +9.4% | 0.00% | – |
| Q1 2022 | $0 | – | 32 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 32 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 32 | -3.0% | 0.00% | – |
| Q2 2021 | $0 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |